AT230024T

Development of dna probes and immunological reagents of human tumor associated antigens

Abstract

(-- A summary 57) The method of manufacturing the immunological reagent as for which * carries out the cell surface antigen of the (correction -- owner) subject human origin is offered. Solution means DNA as for which * carries out the character which can be identified so that DNA isolated from human tumor cells and selection are possible is introduced into the established non-human tumor formative-cells system, Choose and collect transduced cells and this is poured into the 1st suitable rat host, The poured-in transduced cell is induced and the obtained rat host is maintained during the period effective in forming a tumor in a rat host, Obtain tumor cells from the obtained tumor, solid-phase-ize the antiserum generated to that tumor cell to the non-human non-tumor formative-cells system established above-mentioned, pour an antiserum solid phase-ized cell into the 2nd suitable host, and this host is screened, Extraction and hype ーマ are adjusted for a spleen from the 2nd host who identified the host who generates the serum reacted to human tumor cells, and was identified by making it such, and the hype ーマ cell lines which produce the antibody which recognizes a cell surface antigen specifically and is combined are collected.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

42 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
60380490United States of AmericaA
9107912United States of AmericaW

Members42

Family members, oldest first
DocumentOfficeKind
CA2094378A1CanadaA1
WO9208131A1World Intellectual Property Organization (WIPO)A1
AU8931491AAustraliaA
JPH06505147AJapanA
EP0641385A4European Patent Office (EPO)A4
EP0641385A1European Patent Office (EPO)A1
AU660001B2AustraliaB2
CA2209941A1CanadaA1
WO9621671A1World Intellectual Property Organization (WIPO)A1
AU4751196AAustraliaA
EP0804458A1European Patent Office (EPO)A1
WO9810098A1World Intellectual Property Organization (WIPO)A1
AU4182697AAustraliaA
US5851764AUnited States of AmericaA
JPH11502404AJapanA
AU709056B2AustraliaB2
EP0951567A1European Patent Office (EPO)A1
US6159751AUnited States of AmericaA
US6184032B1United States of AmericaB1
US2001014474A1United States of AmericaA1
JP2001292767AJapanA
JP3256227B2JapanB2
JP2002159293AJapanA
EP0804458A4European Patent Office (EPO)A4
EP0951567A4European Patent Office (EPO)A4
US2002155437A1United States of AmericaA1
EP0641385B1European Patent Office (EPO)B1
AT230024TThis recordAustriaT
ATE230024T1AustriaT1
DE69133185D1GermanyD1
JP3376357B2JapanB2
JP3445586B2JapanB2
US2004203063A1United States of AmericaA1
US6811972B1United States of AmericaB1
US6869760B2United States of AmericaB2
US2005163709A1United States of AmericaA1
US2005250206A1United States of AmericaA1
EP0951567B1European Patent Office (EPO)B1
AT330028TAustriaT
ATE330028T1AustriaT1
DE69736122D1GermanyD1
DE69736122T2GermanyT2